<--- Back to Details
First PageDocument Content
Emerging technologies / Condensed matter physics / Physics / Nanoparticle / Ultraviolet radiation / Colloidal gold / Epidermal growth factor receptor / Quantum dot / Experimental cancer treatment / Nanomaterials / Nanotechnology / Materials science
Date: 2015-03-03 20:56:05
Emerging technologies
Condensed matter physics
Physics
Nanoparticle
Ultraviolet radiation
Colloidal gold
Epidermal growth factor receptor
Quantum dot
Experimental cancer treatment
Nanomaterials
Nanotechnology
Materials science

Gold Nanoparticles May Simplify Cancer Detection

Add to Reading List

Source URL: phys.org

Download Document from Source Website

File Size: 31,94 KB

Share Document on Facebook

Similar Documents

AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC

DocID: 1rVAJ - View Document

UNIVERSITÄTSKLINIKUM Schleswig-Holstein Immuntherapie des Glioblastoms Sampson et al. - Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor

DocID: 1rgeq - View Document

Tyrosine kinase receptors / Peptidase / Clinical medicine / Cancer / Medicine / Oncogenes / Tyrosine kinases / HER2/neu / Cathepsin B / Epidermal growth factor receptor / ErbB / Cathepsin Z

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

DocID: 1rdcC - View Document

Tyrosine kinase receptors / Statistics / Cluster analysis / Data analysis / Computational statistics / Hierarchical clustering / Network analysis / Anaplastic lymphoma kinase / K-means clustering / Tyrosine kinase / Dendrogram / Epidermal growth factor receptor

Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U

DocID: 1qMPs - View Document

Lung cancer / Clinical medicine / Cancer / Tyrosine kinase inhibitors / Boehringer Ingelheim / Health / T790M / Protein kinase inhibitor / Epidermal growth factor receptor / Non-small-cell lung carcinoma / Targeted therapy

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

DocID: 1qm1i - View Document